Forts Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 1.00 Cr
- Revenue Growth 41.92%
- Profit Growth 417.39%
- Ebitda 137.33%
- Net Worth 5.15%
- Total Assets 43.39%
About Forts Biotech
Forts Biotech Private Limited (FBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 November 2010 and has a history of 14 years and three months. Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.00 Cr.
Deepak Goyal, Dinesh Goyal, and Jai Mundewala serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232RJ2010PTC033295
-
Company No.
033295
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Nov 2010
-
Date of AGM
25 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Forts Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Goyal
|
Director | 10-Nov-2010 | Current |
|
Dinesh Goyal
|
Director | 15-Jul-2017 | Current |
|
Jai Mundewala
|
Director | 15-Jul-2017 | Current |
Financial Performance of Forts Biotech.
Forts Biotech Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 41.92% increase. The company also saw a substantial improvement in profitability, with a 417.39% increase in profit. The company's net worth moved up by a moderate rise of 5.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Forts Biotech?
In 2018, Forts Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Star Valley Buildhome Private LimitedDeepak Goyal is a mutual person
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2016 | Others | ₹1.00 Cr | Open |
How Many Employees Work at Forts Biotech?
Unlock and access historical data on people associated with Forts Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Forts Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Forts Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
